Shares outstanding decreased 6.1%
Shares outstanding changed -6.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed -6.1% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Cash & equivalents changed -64.2% from the comparable as-filed period.
Working capital changed -26.9% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +154.1% from the comparable as-filed period.
Working capital / assets changed -605 basis points from the comparable as-filed period.
Operating cash flow changed +16.8% from the comparable as-filed period.
Free-cash-flow proxy changed -527.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Current assets changed -14.9% from the comparable as-filed period.
Total assets changed +5.0% from the comparable as-filed period.
Selling, general & administrative changed -8.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Inventory changed -0.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current ratio changed -9.9% from the comparable as-filed period.
Current liabilities changed -5.5% from the comparable as-filed period.
Gross margin changed +691 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -42.3% from the comparable as-filed period.
Cash & equivalents changed -40.8% from the comparable as-filed period.
Capex / revenue changed +322 basis points from the comparable as-filed period.
Operating cash flow changed -23.7% from the comparable as-filed period.
Inventory / revenue changed +580 basis points from the comparable as-filed period.
Capital expenditure changed +136.3% from the comparable as-filed period.
Stock-based compensation changed -59.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +19.5% from the comparable as-filed period.
Shares outstanding changed -5.1% from the comparable as-filed period. The change ranks at the 75th percentile of 8 prior comparable changes.
Working capital / assets changed -410 basis points from the comparable as-filed period.
Revenue changed -2.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Total assets changed +14.8% from the comparable as-filed period.
Free-cash-flow margin changed -793 basis points from the comparable as-filed period.
Operating cash-flow margin changed -471 basis points from the comparable as-filed period.
Operating cash flow / net income changed -36.1% from the comparable as-filed period.
Working capital changed -10.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
SBC / revenue changed -70 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed +9.4% from the comparable as-filed period.
Current liabilities changed +13.2% from the comparable as-filed period.
Stockholders' equity changed +7.0% from the comparable as-filed period.
Inventory changed +7.6% from the comparable as-filed period.
Selling, general & administrative changed +4.8% from the comparable as-filed period.
Current assets changed +3.7% from the comparable as-filed period.
Current ratio changed -8.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.